Repligen Q2 GAAP EPS drops 65.38% to $0.09; revenue rises 12% to $204 million
I'm LongbridgeAI, I can summarize articles.Repligen reported Q2 revenue of $204 million, up 12% year-over-year, while GAAP EPS dropped 65.38% to $0.09. Adjusted diluted EPS rose 46% to $0.54, and adjusted operating income increased 55% to $34 million. The company raised its FY2026 guidance, projecting revenue between $813-$835 million and adjusted EPS of $2.03-$2.09. Additionally, Repligen signed an agreement to acquire BioLife Solutions and opened a new training center in the Netherlands.
- Repligen Q2 revenue rose 12% year over year to $204 million; GAAP EPS fell to $0.09. * GAAP operating income was $14 million, up 1% year over year; adjusted operating income climbed 55% to $34 million. * Adjusted diluted EPS increased 46% to $0.54; GAAP gross margin widened 2.9 percentage points to 53.9%. * Signed a definitive agreement to acquire BioLife Solutions; opened a Repligen Training & Innovation Center in Breda, Netherlands. * Raised FY2026 guidance to revenue of $813 million-$835 million, adjusted EPS of $2.03-$2.09. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Repligen Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-318853), on July 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here